<p>CF-370 is the first engineered lysin therapeutic targeting Gram-negative pathogens allowed to enter a human trial YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation
<p>The EURUSD has extended to a new session high as London/European traders look toward the end of week. The price is approaching the swing high from Monday near 1.10449. The high price from las
Leave a Comment